Skip to main content
Clinical Trials/NCT03705455
NCT03705455UnknownNot Applicable

Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria

Lifespan Healthcare Resource Limited1 site in 1 country1,800 target enrollmentStarted: November 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
1,800
Locations
1
Primary Endpoint
Proportion of timely and complete vaccine uptake after ISAP SMS Intervention

Study Overview

Brief Summary

The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.

Detailed Description

The ISAP - Immunization Schedule Alert Platform study is investigating the efficacy of ISAP SMS exposure to Caregivers with children( who have fulfilled our inclusion criteria) due for routine childhood Immunisation in influencing decision for timely and complete Immunization uptake. ISAP SMS messages contains information on the Immunization appointment schedule, time ,vaccine to be administered and the address of the Immunization centre.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
6 Weeks to 12 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Caregiver with child due for birth dose vaccination or at 6weeks-OPV1,Penta1,PCV1,Rota1.

Exclusion Criteria

  • •Caregiver with child who have already had OPV1,Penta1,PCV1and Rota

Arms & Interventions

No ISAP SMS

No Intervention

No ISAP SMS will be sent to enrolled caregivers

ISAP SMS

Active Comparator

ISAP SMS will be sent to enrolled caregivers

Intervention: ISAP SMS (Behavioral)

Outcomes

Primary Outcomes

Proportion of timely and complete vaccine uptake after ISAP SMS Intervention

Time Frame: 12 months

Proportion of timely and complete vaccine uptake after ISAP SMS Intervention

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr.Ihedioha Emmanuel Chukwunwike

Principal Investigator

Lifespan Healthcare Resource Limited

Study Sites (1)

Loading locations...

Similar Trials